See also this year's filing and all EDGAR filings for this company.
PDF Report 0000828878_2014_Hh_Biotechnology_Holdings_Co.pdf
Logs
warning | No stock price available | subcommand.plot | {} |
warning | Missing logo | subcommand.report | {} |
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 1.852386642736301e-08, 'aggregate_val': 53984409, 'exp_sum': 53984410, 'exp_to_value': {'RealEstateInvestments': 0, 'IntangibleAssets': 0, 'remainder_Assets': 53984410}} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000828878')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000828878')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000828878')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000828878, Hh Biotechnology Holdings Co
xvar | xval | |
---|---|---|
0 | RealEstateInvestmentPropertyAtCost | 0 |
1 | RealEstateInvestmentPropertyAccumulatedDepreciation | 0 |
2 | remainder_RealEstateInvestments | 0 |
3 | LiabilitiesLongTerm | 0 |
4 | LiabilitiesCurrent | 35,543,124 |
5 | remainder_Liabilities | 0 |
6 | IntangibleAssets | 0 |
7 | remainder_Assets | 59,555,164 |
8 | LeaseIncome | 5,579,651 |
9 | remainder_Revenues | 0 |
10 | CostOfRevenue | 5,046,524 |
11 | DepreciationAndAmortization | 18,590 |
12 | GeneralAndAdministrativeExpense | 1,828,869 |
13 | remainder_Expenses | 1,457,417 |
14 | remainder_NetIncome | 957,351 |
15 | remainder_ComprehensiveNetIncome | 706,781 |
yvar | yval | |
---|---|---|
0 | RealEstateInvestments | 0 |
1 | Liabilities | 35,543,124 |
2 | Assets | 59,555,164 |
3 | Revenues | 5,579,651 |
4 | Expenses | 8,351,400 |
5 | StockholdersEquity | 24,012,040 |
6 | NetIncome | -1,814,398 |
7 | ComprehensiveNetIncome | -1,461,008 |
8 | BaseVar | 140,730,362 |
9 | EconomicCapitalRatio | 0.0924 |